Seeking Alpha

The combination of Tarceva and Nexavar tablets to treat liver cancer didn't improve survival...

The combination of Tarceva and Nexavar tablets to treat liver cancer didn't improve survival rates compared with Nexavar on its own in a Phase III trial. Nexavar is jointly produced by Bayer and Onyx (ONXX -0.45%), while Tarceva, which is already used in lung cancer, is sold by Astellas Pharma and Roche unit Genentech.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)